Merck pill lowers cholesterol by 64% in study, rivaling shots

Merck & Co.’s experimental cholesterol pill slashed levels of the artery-clogging plaque far more than older tablets in the ...

Merck's drug reduced bad cholesterol by up to 64.6% in late-stage trial

March 30 () - Merck's oral drug reduced bad cholesterol by up to ‌64.6% in a late-stage trial, ‌the drugmaker said on Monday, ...

Merck's cholesterol drug meets main goal in head-to-head trial

By Christy Santhosh March 30 (Reuters) - Drugmaker Merck said on Monday its oral drug met the main goal of meaningfully ...

New Pill Slashes “Bad” Cholesterol by 60%

Study could lead to an effective new option to reduce the risk of heart attacks and strokes for millions who cannot control ...
Science Daily

New pill cuts “bad” cholesterol by 60% in major trial

A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of ...

New Oral Pill Enlicitide Cuts 'Bad' Cholesterol By 60% In Landmark Trial

The new oral pill enlicitide cuts bad cholesterol risk by 60% in a new landmark trial. Here are the mechanisms behind it and ...
The Republic

Experimental cholesterol-lowering pill may offer new option for millions

WASHINGTON (AP) — A new kind of pill sharply reduced artery-clogging cholesterol in people who remain at high risk of heart attacks despite taking statins, researchers reported Wednesday. It’s still ...